Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
K. K. Y. Chan, S. Birring, G. Cossa, L. Laks, A. Ing (New South Wales, Australia; London, United Kingdom). CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study. Eur Respir J 2008; 32: Suppl. 52, 771

Member's Comments

No comment yet.

Related content which might interest you: Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Chronic cough in patients with obstructive sleep apnea. Source: International Congress 2018 – Obesity: comorbidities Year: 2018 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Assessing an auto set trial period for obstructive sleep apnoea patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Web-based follow-up of CPAP compliance in obstructive sleep apnea syndrome: A pilot study Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea Year: 2011 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA) Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Laryngeal obstruction in moderate and severe obstructive sleep apnea patients requested higher CPAP level during treatments Source: International Congress 2018 – Sleep and breathing control: phenotypes Year: 2018 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006 Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004